As has been previously mentioned on this web site, cabazitaxel — a second-generation taxane — has a good chance of being approved some time soon for the treatment of patients with castration-resistant prostate cancer (CRPC) who have already progressed after treatment of docetaxel (Taxotere). However, … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: adverse events, cabazitaxel, risk | 11 Comments »
A study from the prestigious Karolinska Institute in Sweden has provided some concrete evidence that — with an appropriately high caseload and experience — robot-assisted laparoscopic prostatectomy (RALP) may, in fact, be associated with a significant reduction in surgical complications by comparison with open, radical retropubic prostatecomy (RRP). … READ MORE …
Filed under: Management, Treatment | Tagged: adverse events, complications, open, radical prostatectomy, RALP | Leave a comment »
A report published by Reuters within the past couple of hours makes some surprisingly assertive claims about the safety of (unspecified forms of) “radiation therapy” in the treatment of prostate cancer. These claims are all the worse for being based on retrospective analysis as opposed to any sort of prospective clinical trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse events, radiation therapy, short-term, surgery | Leave a comment »
There are two news items of significant interest today. One deals with screening behaviors of men living alone; the other with short-term complications following radiotherapy for localized prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: adverse events, radiotherapy, screening | Leave a comment »
There are a lot of news items this weekend. This first batch addresses studies on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, adverse events, clinically insignificant, fatigue, radiotherapy, second-line chemotherapy, surgery | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 